Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

'Robust' new imaging technique combines ultrasound with optical tomography
Researchers with the University of Texas at Arlington received a grant worth $190,000 to continue working on the new modality.
Preop prostate MRI findings predict cancer recurrence at rates similar to pathology, analysis shows
Given the similarities in accuracy between pathology results and preoperative imaging, MRI could have a greater role in risk assessments in the future, experts suggested in AJR.
SPECT/CT helps personalize treatment options for prostate cancer patients
Using SPECT/CT imaging, providers can stratify patients based on their treatment responses and make personalized adjustments accordingly.
New PET technology offers 'clear improvement' of whole-body scan resolution
The new technology achieves this by way of two add-on detectors that simultaneously scan patients during their whole-body PET exam.
New prostate cancer PET imaging agent officially available for commercial use
Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.

Around the web

Radiology Business

Improving interoperability between the PACS and EMR

Radiologists need better access to patient data stored in the electronic medical record, imaging IT expert Rik Primo explains.

Radiology Business

3 key radiology IT systems trends

Imaging IT expert Rik Primo discusses emerging issues he saw at RSNA and HIMSS.

Radiology Business

PHOTO GALLERY of radiology technologies at HIMSS 2023

Many new imaging solutions were on display at the world's largest health informatics conference, held at McCormick Place in Chicago.

'Robust' new imaging technique combines ultrasound with optical tomography

Researchers with the University of Texas at Arlington received a grant worth $190,000 to continue working on the new modality.

September 1, 2023

An international panel of experts recently developed and validated a reporting assessment scoring system that analyzes the location and extent of prostate cancer recurrence.

Preop prostate MRI findings predict cancer recurrence at rates similar to pathology, analysis shows

Given the similarities in accuracy between pathology results and preoperative imaging, MRI could have a greater role in risk assessments in the future, experts suggested in AJR.

July 6, 2023

SPECT/CT helps personalize treatment options for prostate cancer patients

Using SPECT/CT imaging, providers can stratify patients based on their treatment responses and make personalized adjustments accordingly.

June 29, 2023

whole-body pet scanner add-on device presented at #SNMMI 2023

New PET technology offers 'clear improvement' of whole-body scan resolution

The new technology achieves this by way of two add-on detectors that simultaneously scan patients during their whole-body PET exam.

June 26, 2023

New prostate cancer PET imaging agent officially available for commercial use

Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.

June 21, 2023

Prostate cancer size is frequently underestimated on imaging

Newly published data recently revealed just how common the extent of prostate cancer is underestimated based on imaging measurements.

June 12, 2023

Two examples of PSMA-PET scans showing numerous prostate cancer metastases spread throughout the body. Many of these smaller tumors would not have been detected on previous standard-of-care imaging. Photo on left courtesy of SNMMI, right University of Chicago. #PSMAPET

PSMA-PET a more cost-effective option for patients long-term compared to standard prostate imaging

The findings support adopting F-18 DCFPyL PET/CT as the standard of care for prostate cancer staging, authors of a new Scientific Reports paper concluded.

May 25, 2023

Accessibility, reimbursement and other issues limit uptake of PET/CT among oncologists, survey reveals

Difficulty obtaining PET/CT scans was reported by 55% of respondents, with 21% citing this as the greatest barrier in treating classic Hodgkin lymphoma.

April 27, 2023